Exact Sciences Corporation (NASDAQ:EXAS) recently ticked higher on weak volume. About 1.6 million contracts were traded on 08-Nov-18 compared to daily average volume of 2.1 million shares. The first sale was made at $75.15 but later the stock became weaker, and closed with a gain of 0.79%. It was last traded at $76.08 apiece.Exact Sciences Corporation (EXAS): Outperform Candidate With 15.67% Upside Potential
Exact Sciences Corporation is maintained at an average outperform rating by 13 stock analysts, and there are at least 9.01% of shares outstanding that are currently legally short sold. The shares went up by 12.96% in value last month. Year-to-date it jumped 44.8%. Analysts are turning out to be more optimistic than before, with 10 of analysts who cover Exact Sciences Corporation (NASDAQ:EXAS) advice adding it to buy candidate list. Wall Street experts also assign a $88 price target on Exact Sciences Corporation, pointing towards a 15.67% rally from current levels. The stock is trading for about -6.33% less than its 52-week high.
Exact Sciences Corporation (EXAS) remained successful in beating the consensus-estimated -$0.43 as it actually earned -$0.37 per share in its last reported financial results. Revenue, on the other hand, scored 5.98% growth from the previous quarter, coming up with $109.04 million.EXAS Adds 3.78% In A Week
This company shares (EXAS) so far managed to recover 103.64% since collapsing to its 52-week low. Over a week, it has seen its stock price volatility to stay at 2.99% while shortening the period to a week, volatility was 5.55%. The share price has already crossed its 20 days moving average, floating at a distance of 13.51% and sits 5.67% higher versus its 50 days moving average. When looking at the past five sessions, the stock returned 3.78% gains and is up by 30.98% compared with its 200-day moving average of $63.06. Also, Exact Sciences Corporation (EXAS) needs to expand a 25.73% increase it experienced over the past twelve months.
As regular trading ended, DexCom, Inc. (DXCM) stock brought in a $3.76 rise to $148.41. The day started at a price of $137 but then traded as high as $145 before giving part of the gains back. As for this week, analysts appear content to stick with their bright outlook with the consensus call at 1.8. DexCom, Inc. is given 9 buy-equivalent recommendations, 0 sells and 5 holds. The company shares sank -0.1% from their peak of $148.56 and now has a $13.44 billion market value of equity.
DXCM’s mean recommendation on Reuter’s scale slipped from 1.84 thirty days ago to 1.79 now, which indicates a buy consensus from the analyst community. They see DexCom, Inc. (DXCM) price hitting a mean target of $147.5 a share, meaning the stock still has potential that could drag the price another -0.61% . Also, the recent close suggests the stock is underpriced by 14.55% compared to the most bullish target.
The company had seen its current volume reaching at 1.49 million shares in the last trade. That compares with the recent volume average of 1.13 million. At the close of regular trading, its last week’s stock price volatility was 5.46% which for the month reaches 5.52%. DexCom, Inc. dipped to as low as $132.48 throughout the day and has returned 158.6% in this year. At one point in the past year, the shares traded as low as $48.9 but has recovered 203.5% since then.